• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Cochlear’s hearing implant lands a date with the FDA

Cochlear’s hearing implant lands a date with the FDA

October 25, 2013 By Arezu Sarvestani

Cochlear lands a date with the FDA for hearing implant

Australia’s Cochlear Ltd. (ASX:COH) landed a date with the FDA where experts on the agency’s Ear, Nose & Throat Devices advisory panel will review information and make a recommendation on the company’s Nucleus Hybrid L24 implantable hearing aid.

Cochlear hopes to win approval to treat patients over the age of 18 who are suffering from residual low- frequency hearing sensitivity and bilateral severe to profound high frequency sensorineural hearing loss, according to a notice in the Federal Register.

News of the meeting preceded a boost in COH shares, which rose 1.1% to $58.87 as of the close of the Australian market yesterday. The panel’s public meeting is slated to take place November 8 in Silver Spring, Md., according to the agency notice.

In a study of 66 adult hearing-impaired subjects, researchers determined that the Nucleus Hybrid L24 device resulted in "significantly improved" speech perception, sound quality and quality of life compared with preoperative hearing aids, according to a study published online in PubMed. Nearly 90% of the study participants maintained "useful residual hearing," researchers reported.

The panel date is more good news for Cochlear, which in August announced European market approval for the next-generation Nucleus 6, which the company called the smallest behind-the ear sound processor on that market.

Filed Under: Food & Drug Administration (FDA), Implants, News Well, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Cochlear Americas, Cochlear Ltd., Hearing

More recent news

  • Former Intuitive sales leader joins surgical robot maker Virtual Incision as CEO
  • Smith+Nephew to open first orthopedic ambulatory surgery center in the UK
  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy